Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Open Lending to Attend the Canaccord Genuity 44th Annual Growth Conference
-
Stran & Company Reports Preliminary Selected Unaudited Results for the Six Months Ended June 30, 2024
-
UDF IV Files Proxy Statement and Mails Letter to Shareholders
-
180 Degree Capital Corp. Notes Agreement With Lantronix, Inc. for Nomination of Directors at Upcoming Annual Meeting of Stockholders
-
Alarum to Release Second Quarter Results on August 26, 2024
-
DeFi Technologies Subsidiary Valour Inc. Announces Rebalancing of the Valour Digital Asset Basket 10 (VDAB10) and the STOXX Bitcoin Suisse Index
-
OptimumBank Announces New Participants at the Inaugural Virtual Banking Conference on September 12, 2024, via Live Webcast
-
Complete Solaria to Report Second Quarter Financial and Operational Results on August 14, 2024
-
Safe and Green Holdings Announces Preliminary Term Sheet to Refinance Waldron Facility
-
S&P 500 Nuclear Energy Stocks Prices Surge 800% on Largest U.S. Power Grid
-
Wave Life Sciences Receives FDA Rare Pediatric Disease Designation for WVE-N531 for the Treatment of Duchenne Muscular Dystrophy
-
Xenon Expands Leadership Team with Matthew D. Ronsheim, Ph.D. as Chief Operating Officer
-
Safety Shot Announces Powerful Data Analysis From Recent Clinical Trial Confirming Dramatic Reduction of Blood Alcohol Content
-
OMNIQ Expands AI Access Control System to an Additional Major Medical Center in Texas
-
SRM Expands Distribution with ICEE Brand Sip With Me Cups Coming Soon to a Theater Near You
-
Above Food to Participate in the 44th Annual Canaccord Genuity Growth Conference
-
ConnectM Publishes Impact Scorecard for the Six Months Ended June 30, 2024
-
Telomir Pharmaceuticals Mourns the Passing of Chairman and CEO Dr. Christopher Chapman
-
CytoDyn Announces Completion of FDA Meeting on Phase II Study of Leronlimab in Patients with Relapsed/Refractory Microsatellite Stable Colorectal Cancer
-
Aprea Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
-
Stran & Company Reports Preliminary Selected Unaudited Results for the Six Months Ended June 30, 2024
-
Verizon to upgrade SD-WAN at 49 National Labor Relations Board locations
-
Orion Corporation: Managers’ transactions – Satu Ahomäki
-
Associa Announces Webinar on Corporate Transparency Act
-
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients
-
Draganfly Signs Leading Drone Solution Provider for Australian Government and Enterprise Value Added Distributorship
-
Archrock Announces Private Offering of $500 Million of Senior Notes
-
Dr. Charlie Fox Joins Utah Gastroenterology in Salt Lake City
-
Ocean Power Technologies Continues Global Expansion with Signing of Strategic Reseller Agreements in All Key Continents
-
Maris-Tech Ltd. Announces Preliminary Gross Revenues for the First Half of 2024 of Approximately $3,000,000-$3,400,000
-
IN8bio Solidifies Position as a Clinical Leader of Gamma-Delta T Cell Therapy in Oncology with 100% of Treated AML Patients in Complete Remission and Receives FDA Guidance for Registrational Trial of
-
Latham Group, Inc. to Participate at Upcoming Conference
-
Scandinavian Tobacco Group A/S: Transactions in connection with share buy-back programme
-
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
-
Maravai LifeSciences Announces August and September 2024 Investor Conference Schedule
-
American Rare Earths Forges a New Path to Accelerate Development of Key Wyoming Asset
-
Xometry Unveils Instant Pricing, Lead Time Offerings For Tube Cutting, Tube Bending
-
Taysha Gene Therapies Reports Second Quarter 2024 Financial Results and Provides Corporate Update
-
Enservco Transforms Business With Close of Buckshot Acquisition and Share Exchange With Star Equity Holdings
-
New veteran mental health initiative launches volunteer recruitment campaign
-
Tenax Therapeutics Announces Closing of $100 Million Private Placement and Plans to Accelerate the Oral Levosimendan Phase 3 Program
-
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia, the Prototypic Nociplastic Pain Syndrome, at the IASP 2024 World Congress on Pain
-
Shirofune Showcases Advanced, Results-Driven eCommerce and Omnichannel Advertising Automation at eTail East 2024
-
Caribou Biosciences Appoints Tina Albertson, MD, PhD, as Chief Medical Officer
-
ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer
-
Humacyte to Present Second Quarter Financial Results and Provide Corporate Update on August 13, 2024
-
Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
-
CervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate Updates
-
Synchronoss Technologies to Present at the Sidoti Virtual Investor Conference
-
Avalyn Announces Initiation of Phase 1b Clinical Study for AP02, its Novel Inhaled Nintedanib
